The world of migraine is complex and often misunderstood, even though it’s one the most disabling neurologic disorders in the world. Despite its prevalence, this common disease remains deeply stigmatized.

Teshamae Monteith, M.D., a nationally recognized headache expert, sheds light on groundbreaking research, pharmaceutical innovations and emerging treatments that aim to reshape the way we think about and treat migraines.

Prostate cancer is the 2nd most common cause of cancer death in U.S. men. While initial treatments offer hope, many patients find that their cancer returns with often fatal outcomes. But what if the key to stopping this deadly progression lies in our genes?

Dr. Nima Sharifi, scientific director of the Desai Sethi Urology Institute, discovered a specific genetic variant that enables tumors to bypass treatments, effectively producing their own hormones to fuel cancer growth.

Tune in!

Dr. David Davis, is breaking new ground in understanding how toxins, especially microplastics, may contribute to neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's.

In this episode of Inside U Miami Medicine, Dr. Davis shares his journey and the groundbreaking methodologies he developed to detect and study these toxins. From cyanobacterial blooms to airborne plastic particles, he reveals the urgent need to address these environmental threats.

We’re exploring visionary breakthroughs in the field of ophthalmology with Eduardo Alfonso, M.D., director of Bascom Palmer Eye Institute. Dr. Alfonso has his sight set on an ambitious project - whole eye transplant. He and his team are currently exploring the use of an ECMO device to preserve a donated eye, enabling them to apply gene therapy and stem cells, replace specific parts of the organ, and enhance its functionality.

Tune in to hear more about this fascinating venture, as well as other breakthroughs and challenges in the field that are providing new avenues for disease modeling, drug screening and cellular therapies.

Dr. Helen Bermudez, a gastroenterology fellow, overcame immense challenges to pursue her dream. Born in Cuba, she immigrated to the U.S. at age 15. She spoke no English but carried an unwavering dedication to help others through medicine. Tune in as we explore Dr. Bermudez’s story of resilience and the advice she offers others facing similar paths.

Dr. Ashish Shah, a neurosurgeon and brain cancer researcher at Sylvester Comprehensive Cancer Center, is weaponizing viruses to make brain cancer cells more susceptible to chemotherapy and radiation. It’s a delicate process that involves delivering viral-based gene therapy directly into the tumor or tumor cavity to alter the fundamental genome of the cancer cells.

Tune in to learn how this treatment is offering new hope for glioblastoma patients.

When the very treatment keeping a patient alive also exacts a heavy toll on lives, researchers are compelled to ask, “Is there another way?”

Glioblastoma is a brutal brain cancer. It is aggressive, common and nearly always fatal. Standard treatments of radiation and chemotherapy often leave patients with cognitive problems and a diminished quality of life.

But Dr. Macarena de la Fuente, chief of the Neuro oncology Division at Sylvester Comprehensive Cancer Center, envisions a future that empowers patients to manage tumors with fewer compromises. She investigates new drugs that prolong progression-free survival and delay the need for toxic treatments.

In some of the clinical trials she and her team are advancing, the tumors even shrank in size.

In the vast landscape of medical research, few areas are as intricate and nuanced as traumatic brain injury. However, amidst these profound challenges lies the relentless pursuit of understanding and innovation spearheaded by pioneers like Dr. Dalton Dietrich.

Dr. Dietrich, scientific director of the Miami Project to Cure Paralysis, recently joined the Inside U Miami Medicine podcast to share the latest neuroscience discoveries and how novel therapies – like targeted hypothermia – may protect and enhance recovery of neurological function. He also addresses the question on many people's minds: "Does TBI lead to dementia?"

Tune in.